Prescribing with Confidence: 24-Month Efficacy Highlights for ZEISS MyoCare
The latest 24-month clinical data on ZEISS MyoCare spectacle lenses deliver the evidence-based clarity eye care professionals (ECPs) need to stay at the clinical edge. Multi-center trial findings demonstrate that ZEISS MyoCare significantly slows myopia progression—reducing axial length elongation to just 0.08 mm/year in Caucasian children and 0.20 mm/year in Asian children. By effectively matching non-myopic physiological eye growth, this technology offers clinicians a proven,…

